We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$84.2M
AUM Growth
+$472K
Cap. Flow
+$1.64M
Cap. Flow %
1.94%
Top 10 Hldgs %
44.61%
Holding
75
New
3
Increased
26
Reduced
8
Closed
13
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
SABR icon
Sabre
SABR
+$1.72M
2
WKC icon
World Kinect Corp
WKC
+$1.36M
3
BRKL icon
Brookline Bancorp
BRKL
+$1.26M
4
ALCO icon
Alico
ALCO
+$641K
5
OSPN icon
OneSpan
OSPN
+$599K

Top Sells

Rank Stock Value
1
AI icon
C3.ai
AI
+$1.34M
2
CBAY icon
Cymabay Therapeutics
CBAY
+$1M
3
B icon
Barrick Mining
B
+$945K
4
AEM icon
Agnico Eagle Mines
AEM
+$780K
5
YOU icon
Clear Secure
YOU
+$686K

Sector Composition

Rank Sector Weight
1 Healthcare 36.45%
2 Industrials 11.96%
3 Energy 9.91%
4 Financials 9.6%
5 Consumer Discretionary 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VNO icon
51
Vornado Realty Trust
VNO
$6.2B
$307K 0.36%
20,000
+10,000
+100% +$202K
2022 Q2
3 quarters
EDSA icon
52
Edesa Biotech
EDSA
$25.7M
$296K 0.35%
46,429
+1,747
+4% +$18.2K
2022 Q3
2 quarters
LTRN icon
53
Lantern Pharma
LTRN
$9.96M
$290K 0.34%
60,000
– –
2022 Q1
4 quarters
NKTR icon
54
Nektar Therapeutics
NKTR
$1.29B
$281K 0.33%
26,667
+18,334
+220% +$555K
2020 Q4
9 quarters
ADVM icon
55
DELISTED
Adverum Biotechnologies
ADVM
$269K 0.32%
37,500
+27,500
+275% +$194K
2022 Q4
1 quarter
KRON icon
56
DELISTED
Kronos Bio
KRON
$263K 0.31%
180,000
+150,000
+500% +$288K
2022 Q4
1 quarter
FEMY icon
57
Femasys
FEMY
$14.6M
$262K 0.31%
12,069
– –
2021 Q2
7 quarters
PK icon
58
Park Hotels & Resorts
PK
$3.17B
$247K 0.29%
+20,000
New +$263K
2023 Q1
0 quarters
AMRX icon
59
Amneal Pharmaceuticals
AMRX
$6.7B
$209K 0.25%
150,000
– –
2022 Q2
3 quarters
SMSI icon
60
Smith Micro Software
SMSI
$12.9M
$186K 0.22%
4,000
-625
-14% -$56.1K
2020 Q4
9 quarters
NEUE icon
61
DELISTED
NeueHealth
NEUE
$110K 0.13%
6,250
– –
2021 Q3
6 quarters
NBSE icon
62
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$22K 0.03%
6,000
-11,500
-66% -$53.1K
2021 Q3
6 quarters
AEM icon
63
Agnico Eagle Mines
AEM
$95B
– –
-15,000
Closed -$780K –
AI icon
64
C3.ai
AI
$1.96B
– –
-120,000
Closed -$1.34M –
C icon
65
Citigroup
C
$207B
– –
-15,000
Closed -$678K –
CGAU icon
66
Centerra Gold
CGAU
$4.3B
– –
-25,000
Closed -$130K –
CTMX icon
67
CytomX Therapeutics
CTMX
$525M
– –
-75,000
Closed -$120K –
B icon
68
Barrick Mining
B
$66.7B
– –
-55,000
Closed -$945K –
INTT icon
69
inTEST
INTT
$167M
– –
-55,000
Closed -$567K –
OGN icon
70
Organon & Co
OGN
$3.61B
– –
-20,000
Closed -$559K –
PAAS icon
71
Pan American Silver
PAAS
$18.1B
– –
-15,000
Closed -$245K –
SSRM icon
72
SSR Mining
SSRM
$6.47B
– –
-15,000
Closed -$235K –
WBD icon
73
DELISTED
Warner Bros
WBD
– –
-50,000
Closed -$474K –
YOU icon
74
Clear Secure
YOU
$4.63B
– –
-25,000
Closed -$686K –
CBAY icon
75
DELISTED
Cymabay Therapeutics
CBAY
– –
-160,000
Closed -$1M –
1 2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q1 2023 Portfolio in Review

As of Q1 2023, CM Management held 75 positions worth $84.2M, up 0.56% from $83.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

CM Management's Q1 2023 filing shows 3 new, 26 increased, 8 reduced and 13 closed positions. Its largest new stake was Sabre: 300,000 shares worth $1.29M. The largest sale was C3.ai, an estimated $1.34M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Industrials and Energy.

  • CM Management's largest Q1 2023 buy was Sabre: 300,000 shares worth $1.29M.
  • CM Management added most to Brookline Bancorp in Q1 2023, an estimated $1.26M increase.
  • CM Management's biggest Q1 2023 reduction was Cytokinetics, cutting an estimated $612K.
  • CM Management fully exited C3.ai in Q1 2023, selling an estimated $1.34M.
  • CM Management's ten largest holdings make up 45% of its $84.2M portfolio in Q1 2023.
  • CM Management opened 3 new positions and closed 13 in Q1 2023.
  • CM Management's portfolio value rose 0.56% quarter-over-quarter to $84.2M.

Based on CM Management's 13F filing for Q1 2023, filed 8 May 2023.